For research use only. Not for human or veterinary use. Supplied as a lyophilized powder for laboratory research.
Net peptide content is the share of a powder’s total weight that is actually peptide. HPLC purity answers a different question: what share of the detected chromatographic peak area belongs to the target peptide. A lyophilized peptide can show very high HPLC purity and still contain substantial non-peptide mass, mainly counter-ions such as trifluoroacetate (TFA) and water [1][2]. In one published reference-material study, the TFA counter-ion alone was nearly 25% of the mass [1].
Peptide purity vs peptide content
| HPLC purity | Net peptide content | |
|---|---|---|
| Question | What fraction of detected peaks is the target? | What fraction of total weight is peptide? |
| Counts counter-ions? | No (not seen by the UV method) | Yes, as non-peptide mass |
| Counts water? | No | Yes |
| Typical methods | Reversed-phase HPLC/UPLC with UV [3] | Amino-acid analysis, qNMR, mass balance [1][2] |
Where the non-peptide mass comes from
- TFA counter-ions: solid-phase synthesis uses TFA as the cleavage agent and purification uses it as an ion-pairing reagent, so peptides are usually obtained as TFA salts [4]. Positively charged residues attract more counter-ions, so content varies with sequence [4].
- Water: lyophilized solids retain residual moisture; water was 5.46% of the mass in the sublancin study below [2].
- Related impurities and inorganic residues, usually small.
Net peptide content calculation: two published examples
Mass balance subtracts every measured non-peptide component from 100%:
| Study | Water | Counter-ion (TFA) | Related compounds | Inorganics | Peptide purity (mass fraction) |
|---|---|---|---|---|---|
| Sublancin, Chen et al. 2026 [2] | 5.46% | 15.48% | 0.4% | 0.056% | 78.60% by mass balance; 77.58% by amino-acid IDMS |
| Angiotensin II reference material, Melanson et al. 2018 [1] | Not itemized in abstract | Nearly 25% by mass | Corrected for | Not itemized | 691 ± 9 mg/g (69.1%) |
In both cases the peptide accounted for well under 80% of the weight even after careful purification.
Why counter-ion content matters in research
- Assay concentration: weighing powder without accounting for content overstates the amount of peptide.
- Biological effects of TFA: in a 1999 study, TFA at 10⁻⁸ to 10⁻⁷ M reduced osteoblast and chondrocyte cell numbers in culture [5].
- Counter-ion exchange: TFA can be exchanged for chloride by repeated freeze-drying with HCl, or for weaker-acid counter-ions such as acetate by HPLC or ion-exchange methods [4][6]. A 2025 study recommends quantifying and specifying counter-ion content for assays with synthetic peptides [4]. See Peptide Acetate vs TFA Salt.
Frequently asked questions
The percentage of a peptide powder’s weight that is peptide, after accounting for counter-ions, water and other non-peptide components [1][2].
No. Purity is the share of detected HPLC peak area; content is the share of total weight. Counter-ions and water lower content without affecting purity [1][4].
By mass balance (subtracting measured water, counter-ion, impurity and inorganic fractions) or by amino-acid analysis or qNMR [1][2].
TFA is used to cleave peptides from the synthesis resin and as an ion-pairing reagent in purification, so peptides often end up as TFA salts [4].
Research materials and certificates
- Quantity results on MFP certificates: COA Library · BPC-157
- Related: Peptide Purity Grades Explained · How to Read a Peptide COA
References
- Melanson JE, Thibeault MP, Stocks BB, Leek DM, McRae G, Meija J. Purity assignment for peptide certified reference materials by combining qNMR and LC-MS/MS amino acid analysis results: application to angiotensin II. Anal Bioanal Chem. 2018;410(26):6719-6731. doi:10.1007/s00216-018-1272-7. PMID: 30143839
- Chen W, Yan J, Yang M, et al. SI-traceable purity assignment for peptide sublancin using mass balance approach and isotope dilution mass spectrometry based on amino acid analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2026;1277:125038. doi:10.1016/j.jchromb.2026.125038. PMID: 41916078
- Lian Z, Wang N, Tian Y, Huang L. Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives. J Am Soc Mass Spectrom. 2021;32(8):1852-1860. doi:10.1021/jasms.0c00479. PMID: 34110145
- Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals (Basel). 2025;18(8):1163. doi:10.3390/ph18081163. PMID: 40872554
- Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 1999;277(5):E779-83. doi:10.1152/ajpendo.1999.277.5.E779. PMID: 10567002
- Roux S, Zékri E, Rousseau B, Paternostre M, Cintrat JC, Fay N. Elimination and exchange of trifluoroacetate counter-ion from cationic peptides: a critical evaluation of different approaches. J Pept Sci. 2008;14(3):354-9. doi:10.1002/psc.951. PMID: 18035848
Research-use-only disclaimer: All products from My Freedom Peptides are supplied as a lyophilized powder for laboratory research. They are for research use only and not for human or veterinary use. My Freedom Peptides LLC is a chemical supplier. It is not a 503A compounding pharmacy or a 503B outsourcing facility. These statements have not been evaluated by the Food and Drug Administration. Products are not intended to diagnose, treat, cure, or prevent any disease.
